key: cord-0269949-yxg88z73
authors: Wang, D.; Chukwu, A.; Mwanyika-Sando, M.; Abubakari, S. W.; Assefa, N.; Madzorera, I.; Hemler, E. C.; Ismail, A.; Lankoande, B.; Mapendo, F.; Millogo, O.; Workneh, F.; Azemraw, T.; Febir, L. G.; James, C.; Tinkasimile, A.; Asante, K. P.; Baernighausen, T.; Berhane, Y.; Killewo, J.; Oduola, A. M.; Sie, A.; Smith, E. R.; Soura, A. B.; Tajudeen, R.; Vuai, S.; Fawzi, W. W.
title: Levels and determinants of COVID-19 vaccine hesitancy among sub-Saharan African adolescents
date: 2022-05-21
journal: nan
DOI: 10.1101/2022.05.18.22275274
sha: 8bcb20772c36ab91214b443e6941921edeebc502
doc_id: 269949
cord_uid: yxg88z73

COVID-19 vaccine hesitancy among adolescents poses a challenge to the global effort to control the pandemic. This multi-country survey aimed to assess the levels and determinants of COVID-19 vaccine hesitancy among adolescents in sub-Saharan Africa between July and December 2021. The survey was conducted using computer-assisted telephone interviewing among adolescents in five sub-Saharan African countries, Burkina Faso, Ethiopia, Ghana, Nigeria, and Tanzania. A rural area and an urban area were included in each country (except Ghana, which only had a rural area), with approximately 300 adolescents in each area and 2803 in total. Sociodemographic characteristics and perceptions and attitudes on COVID-19 vaccines were measured. Vaccine hesitancy was defined as definitely not getting vaccinated or being undecided on whether to get vaccinated if a COVID-19 vaccine were available. Log-binomial models were used to calculate the adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) for associations between potential determinants and COVID-19 vaccine hesitancy. The percentage of COVID-19 vaccine hesitancy was 15% in rural Kersa, 24% in rural Ibadan, 31% in rural Nouna, 33% in urban Ouagadougou, 37% in urban Addis Ababa, 48% in rural Kintampo, 64% in urban Lagos, 76% in urban Dar es Salaam, and 88% in rural Dodoma. Perceived low necessity, concerns about vaccine safety, and concerns about vaccine effectiveness were the leading reasons for hesitancy. Healthcare workers, parents or family members, and schoolteachers had the greatest impacts on vaccine willingness. Perceived lack of safety (aPR: 3.61; 95% CI: 3.10, 4.22) and lack of effectiveness (aPR: 3.59; 95% CI: 3.09, 4.18) were associated with greater vaccine hesitancy. The levels of COVID-19 vaccine hesitancy among adolescents are alarmingly high across the five sub-Saharan African countries, especially in Tanzania. COVID-19 vaccination campaigns among sub-Saharan African adolescents should address their concerns and misconceptions about vaccine safety and effectiveness.

8 143 between the ages of 10 to 19 years residing in the household. The sampling frames and sampling 144 methods for Burkina Faso, Ethiopia, and Nigeria have been described in detail previously [45] . 

The Round 1 survey was conducted between July and November 2020, and the Round 2 158 survey was conducted between July and December 2021. For the Round 2 survey, all households 159 with adolescents aged 10 to 19 years that participated in the Round 1 survey were contacted . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 21, 2022. The most highly trusted sources of information on COVID-19 vaccines for adolescents were television, radio, or newspaper 302 (85% overall), medical professionals (83% overall), and governmental communications (74% overall) (S1 Table) . 

In conclusion, we show that COVID-19 vaccine hesitancy among adolescents is high 455 across the five sub-Saharan African countries, especially in Tanzania. COVID-19 vaccination . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 21, 2022. ; https://doi.org/10.1101/2022.05.18.22275274 doi: medRxiv preprint

willingness to receive the COVID-19 vaccine, perceptions of the vaccine, self-193 reported determinants of their willingness to be vaccinated, and their trusted information sources

The outcome for the associational analyses was COVID-19 vaccine hesitancy, defined as 198 a response of definitely not getting the COVID-19 vaccine or maybe, unsure, or undecided on 199 whether to get the COVID-19 vaccine if it were available now. We defined vaccine hesitancy as 200 a dichotomous outcome. The potential determinants included age, sex, country, rural residence, 201 currently receiving education, perceived safety of the COVID-19 vaccine among children and 202 adolescents, perceived effectiveness of the COVID-19 vaccine

We used log-binomial models to calculate the prevalence ratios (PRs) and 95%

Older age was associated with a lower prevalence of COVID-19 vaccine hesitancy

313 adolescents in Ghana were 55% more likely to have COVID-19 vaccine hesitancy (aPR: 1.55; 95% CI: 1.28, 1.86), adolescents in 314 Nigeria were 44% more likely to have COVID-19 vaccine hesitancy (aPR: 1.44; 95% CI: 1.23, 1.68), and adolescents in Tanzania 315 were 142% more likely to have COVID-19 vaccine hesitancy (aPR: 2.42; 95% CI: 2.11, 2.78)

COVID-19 vaccines were very effective, adolescents who perceived COVID-19 vaccines to be somewhat effective, not very effective, 321 and not effective at all had 1.9 times

We report that the vaccine willingness of over 15% of adolescents in all areas is affected 401 by the vaccine's country of origin, with COVID-19 vaccines developed in the United States the 402 most accepted

Accordingly, perceived lack of safety and perceived lack of samples, including 44,260 individuals from the United States, Russia, and 10 LMICs 418 in Asia, Africa, and South America [31]. The survey found that vaccine acceptance in LMICs is 419 primarily driven by the desire for personal protection

We find that adolescent boys have less COVID-19 vaccine hesitancy than adolescent 427 girls, consistent with existing evidence. Among Turkish adults, males had a higher probability of

The strengths of this study are the inclusion of multiple countries and cities in sub

Saharan Africa and the measurement of a wide array of potential determinants of COVID-19 across sub-Saharan Africa. Therefore, the results provide important insights into the 448 levels of determinants of COVID-19 vaccine hesitancy in sub-Saharan Africa. Another limitation 449 is that, due to the nature of phone-based interviews, the adolescents included in most areas were 450 those who resided in households with access to a mobile phone. Consequently, the sample might 451 underrepresent adolescents from under-resourced households

Division of Viral Diseases

Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: 480 A Systematic Review and Meta-analysis

Coronavirus Disease 2019 and Vaccination of 482 Children and Adolescents: Prospects and Challenges

COVID-19 multisystem 484 inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection

The evolving 487 epidemiologic and clinical picture of SARS-CoV-2 and COVID-19 disease in children and young 488 people

Multisystem inflammatory syndrome in US children and adolescents

Vaccinating Children against Covid-19 -The Lessons of Measles. The

World Health Organization. Achieving 70% COVID-19 Immunization Coverage by Mid-497

Attitudes Toward COVID-19 Vaccines in

Chinese Adolescents. Frontiers in medicine

Immunogenicity, and Efficacy of 502 COVID-19 Vaccines in Children and Adolescents: A Systematic Review. Vaccines (Basel)

Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of 506 Adolescents -United States

Vaccine hesitancy: Definition, scope and determinants

Top ten global health threats for 2019: the WHO list

Nnorom-Dike O. COVID-19 vaccine 513 rollout: will it affect the rates of vaccine hesitancy in Africa? Public health (London)

Wake AD. The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: 519 "Vaccination Refusal Could Prolong the War of This Pandemic" -A Systematic Review. Risk 520 management and healthcare policy

COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of

523 19. Wake AD. The Acceptance Rate Toward COVID-19 Vaccine in Africa: A Systematic 524 Review and Meta-analysis. Global pediatric health

COVID-19 vaccination 526 intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 527 countries. Infectious diseases of poverty

A global survey of 529 potential acceptance of a COVID-19 vaccine

COVID-19 vaccine hesitancy 531 among youth. Human vaccines & immunotherapeutics.ahead-of-print(ahead-of-print

Parent and Peer Norms are Unique Correlates of COVID

Older 536 adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for 537 informing public health strategies

To be or not to be vaccinated against COVID-19 -The adolescents' perspective -A mixed-540 methods study in Sweden

COVID-542 19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 543 vaccination rollout in sub-Saharan Africa. Human vaccines & immunotherapeutics.ahead-of-544 print

Sociodemographic factors associated 548 with acceptance of COVID-19 vaccine and clinical trials in Uganda: a cross-sectional study in 549 western Uganda

Assessment of Vaccine Hesitancy to a COVID-19 Vaccine 551 in Cameroonian Adults and Its Global Implication. Vaccines (Basel)

Examining Vaccine Hesitancy in Sub-Saharan Africa: A Survey of the Knowledge and Attitudes 554 among Adults to Receive COVID-19 Vaccines in Ghana. Vaccines (Basel)

COVID-19 556 vaccine acceptance and hesitancy in low-and middle-income countries

When it is 559 available, will we take it? Social media users' perception of hypothetical COVID-19 vaccine in

The Pan African medical journal

Acceptance of a 562 COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Frontiers in public 563 health

The relationship of Covid-19 vaccine attitude with 565 life satisfaction, religious attitude and Covid-19 avoidance in Turkey. Human vaccines & 566 immunotherapeutics

Knowledge, attitude, and 568 practice toward COVID-19 vaccination in Kazakhstan: a cross-sectional study. Human vaccines & 569 immunotherapeutics

Understanding COVID-19 vaccine 571 acceptance in Pakistan: an echo of previous immunizations or prospect of change? Expert 572 review of vaccines

Acceptance and 574 attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan

Abdulah DM. Prevalence and correlates of COVID-19 vaccine hesitancy in the general 580 public in Iraqi Kurdistan: A cross-sectional study

Cross-sectional analysis of COVID-19 vaccine 584 intention, perceptions and hesitancy across Latin America and the Caribbean. Travel medicine 585 and infectious disease

587 attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: 588 a cross-sectional study

What Indians Think of 590 the COVID-19 vaccine: A qualitative study comprising focus group discussions and thematic 591 analysis

Investigation of the relationships between perceived 593 causes of COVID-19, attitudes towards vaccine and level of trust in information sources from 594 the perspective of Infodemic: the case of Turkey

adolescents and Young people in Sub-Saharan Africa: opportunities 596 and challenges: UNFPA

Design and 598 Field Methods of the ARISE Network COVID-19 Rapid Monitoring Survey. The American journal 599 of tropical medicine and hygiene

Design and field methods of the ARISE Network Adolescent Health Study. Tropical Medicine & 602 International Health

Dar Es Salaam health and demographic surveillance system (Dar es Salaam HDSS). International 605

Pandemic and Adolescents' Experience in Sub-Saharan Africa: A Cross-Country Study Using a 608 Telephone Survey. The American journal of tropical medicine and hygiene

An ultra-brief screening scale for anxiety and 610 depression: the PHQ-4

A modified poisson regression approach to prospective studies with binary data

Tanzania refuses COVID-19 vaccines. The Lancet

Covid-19: Counting the cost of denial in Tanzania

A global pandemic in the time of 620 viral memes: COVID-19 vaccine misinformation and disinformation on TikTok

Affecting COVID-19 Vaccine Acceptance: An International Survey among Low-and Middle-624 Income Countries. Vaccines (Basel)

Risk Perception and Risk-Taking 626 Behaviour during Adolescence: The Influence of Personality and Gender